Physician profile
Matthew Langenberg
NPI 1407845159
$35,966.45
in general payments reported to CMS, 2019-2025
59 companies · $19K in 2025
The $19K reported for 2025 was more than what 94% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,043 · 2020: $1,417 · 2021: $3,626 · 2022: $1,910 · 2023: $2,076 · 2024: $3,420 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $10K · Travel and Lodging: $3,199 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $89.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,250.00 |
| Food and Beverage | $10,433.44 |
| Travel and Lodging | $3,198.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $89.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $14,718.30 | 2019-2025 | Rotarexs 6 F X 135 Cm, Pristine, Lifestent Solo Vascular Stent |
| Abbott Laboratories | $4,729.77 | 2019-2025 | Perclose Proglide, Esprit, Perclose Prostyle |
| Medtronic, INC. | $3,117.94 | 2021-2025 | Endurant Iis, Turbohawk, Venaseal |
| Endologix LLC | $2,634.69 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Silk Road Medical, INC. | $1,502.86 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $1,348.84 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $1,282.91 | 2019-2020 | |
| Biotissue Holdings INC. | $1,002.67 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $743.82 | 2021-2023 | Xarelto |
| Penumbra, INC. | $685.08 | 2020-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $566.48 | 2020-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Ekos Corporation | $374.39 | 2019 | |
| Nuvasive, INC. | $350.78 | 2021-2022 | |
| Becton, Dickinson and Company | $273.02 | 2023-2024 | Lifestream, Rotarexs 6 F X 135 Cm |
| Stryker Corporation | $258.32 | 2025 | Limflow System, Flowtriever, Clottriever Bold Catheter |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $213.79 | 2019-2024 | (Dd1) Duo Hybrid |
| Surmodics, INC. | $180.97 | 2022-2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Terumo Medical Corporation | $170.96 | 2019-2025 | Azur Cx Detachable, Metacross Otw |
| Cardiovascular Systems INC. | $157.87 | 2019-2021 | |
| Teleflex LLC | $142.30 | 2022-2023 | Arrow |
| Kci USA, INC. | $136.31 | 2019-2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
| Shockwave Medical, INC | $114.72 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Imperative Care, INC | $98.17 | 2025 | Symphony Catheter |
| Lemaitre Vascular, INC. | $90.11 | 2022-2025 | Artegraft Vascular Graft |
| Allergan, INC. | $78.66 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $65.37 | 2019-2020 | |
| Smith+Nephew, INC. | $52.48 | 2023 | Collagenase Santyl |
| Baxter Healthcare | $48.75 | 2020-2022 | |
| Getinge USA Sales, LLC | $47.17 | 2021 | |
| Angiodynamics, INC. | $46.71 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Integra Lifesciences Corporation | $44.54 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $42.39 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $39.51 | 2021-2025 | Gore Excluder Aaa Endoprosthesis |
| Pfizer INC. | $38.53 | 2019-2020 | |
| Tela Bio, INC. | $37.35 | 2020 | |
| Argon Medical Devices, INC. | $35.92 | 2025 | Clot Management |
| Bolton Medical INC | $33.95 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Access Pro Medical, LLC | $33.83 | 2025 | Matriderm |
| Solventum Corporation | $33.04 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo, Prevena |
| Pacira Pharmaceuticals Incorporated | $32.76 | 2019-2021 | |
| Venturemed Group, INC. | $29.77 | 2021 | |
| Tactile Systems Technology INC | $29.39 | 2019-2020 | |
| Neuros Medical, INC. | $27.25 | 2025 | Altius |
| Reflow Medical INC | $27.13 | 2025 | |
| Csl Behring | $23.01 | 2020 | |
| Z-Medica, LLC | $21.65 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.27 | 2025 | |
| Mozarc Medical US LLC | $20.10 | 2024 | Palindrome |
| Biotronik INC. | $19.77 | 2024 | Pulsar-18 T3 |
| Melinta Therapeutics, LLC | $18.75 | 2019 | |
| Convatec INC. | $17.79 | 2022 | |
| Avinger INC. | $16.00 | 2020 | |
| Chiesi USA, INC. | $14.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.29 | 2021 | |
| Shire North American Group INC | $14.21 | 2019 | |
| Cashflow Solutions, LLC | $14.05 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Takeda Pharmaceuticals U.S.A., INC. | $13.96 | 2020 | |
| Kls-Martin L.P. | $11.16 | 2019 | |
| Organogenesis INC. | $5.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Langenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.